|
August 20, 2004
P.P. Luxco Holdings II s.a.r.l., a wholly-owned subsidiary of Picchio Pharma Inc., announced today
that it has acquired an additional 350,000 common shares of Neurochem Inc. representing 1.16% of the
outstanding common shares of Neurochem Inc. through a private purchase from a
U.S. vendor. Following the acquisition, P.P. Luxco Holdings II s.a.r.l. owns
7,068,368 common shares or 23.3% of the issued and outstanding common shares
of Neurochem Inc. Assuming P.P. Luxco Holdings II s.a.r.l. exercised the 4.0
million warrants to purchase shares of Neurochem Inc. which it currently
holds, it would hold 11,068,368 common shares or 30.2% of the issued and
outstanding common shares of Neurochem Inc. The purpose of this acquisition is
to increase P.P. Luxco Holdings II s.a.r.l.'s holdings in Neurochem Inc. While
P.P. Luxco Holdings II s.a.r.l. does not currently intend to further increase
its ownership or control over the common shares of Neurochem Inc., it may
effect trades in such securities in the future, directly or indirectly,
depending on market prices and circumstances.
For further Information:
Mr. Alexandre Girard
Business Analyst
Picchio Pharma Inc.
759 Square Victoria,
Suite 224,
Montreal (Quebec)
H2Y 2J7
Tel: (514) 282-0552
|
